Jamie E Jeon1, Yasal Rajapaksa2, Shaf Keshavjee3

  • 1Latner Thoracic Surgery Research Laboratories, Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada; Department of Physiology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.

概括

转录学揭示了炎症是移植后肺缺血-再输液 (IR) 损伤的关键因素. 这种方法确定生物标志物和治疗目标,以改善患者的治疗结果.